These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 9554246)

  • 21. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
    Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
    Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subdermal contraceptive implants.
    Peralta O; Diaz S; Croxatto H
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts in contraception: Norplant subdermal implant.
    Lynn MM; Holdcroft C
    Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraceptive implant use among inner city teens.
    Glantz S; Schaff E; Campbell-Heider N; Glantz JC; Bartlett M
    J Adolesc Health; 1995 May; 16(5):389-95. PubMed ID: 7662690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
    Power J; French R; Cowan F
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
    Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
    International Collaborative Post-Marketing Surveillance of Norplant
    Contraception; 2001 Apr; 63(4):167-86. PubMed ID: 11376646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of Norplant implants in four counties of rural China: a two-year evaluation.
    Zenger E; Shuhua Q; Huimin F
    Contraception; 1995 Dec; 52(6):349-55. PubMed ID: 8749598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptance, efficacy, and side effects of Norplant implants in four counties in north China.
    Tu P; Qiu S; Fang H; Smith HL
    Stud Fam Plann; 1997 Jun; 28(2):122-31. PubMed ID: 9216032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with elective Norplant removal in black and white women.
    Opara JU; Ernst FA; Gaskin H; Smith L; Nevels HV
    J Natl Med Assoc; 1997 Apr; 89(4):237-40. PubMed ID: 9145628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levonorgestrel implant use among adolescents.
    Mashburn M
    J Pediatr Health Care; 1994; 8(6):255-60. PubMed ID: 7799199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressive symptoms and Norplant contraceptive implants.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Rulin M; Heartwell S; Davidson A
    Contraception; 1998 Apr; 57(4):241-5. PubMed ID: 9649915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraception with progestogens and progesterone during lactation.
    Shaaban MM
    J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.